25 Apr, EOD - Indian

SENSEX 79212.53 (-0.74)

Nifty 50 24039.35 (-0.86)

Nifty Bank 54664.05 (-0.97)

Nifty IT 35562.25 (0.72)

Nifty Midcap 100 53570.2 (-2.55)

Nifty Next 50 64314.9 (-2.41)

Nifty Pharma 21482.55 (-2.24)

Nifty Smallcap 100 16547.2 (-2.45)

25 Apr, EOD - Global

NIKKEI 225 35705.74 (1.90)

HANG SENG 21980.74 (0.32)

S&P 5564.5 (0.75)

LOGIN HERE

companylogoGlobal Longlife Hospital and Research Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543520 | NSE Symbol : | ISIN : INE0J2K01014 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
22-Oct-2024 28-Oct-2024 Half Yearly Results Half Yearly Results Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 ,inter alia, to consider and approve Unaudited Financial Results for the Half year ended on September 30, 2024 Financial Results for the Half year ended September 30, 2024 along with the Limited Review Report. (As Per BSE Announcement dated on 28.10.2024)
30-Aug-2024 30-Aug-2024 Change in Auditors Appointment of M/s. Manish Dave & Co., Chartered Accountants as the Internal Auditor of the company to conduct internal audit for the FY 2024-2025. Appointment of Ms. Hetal Thakkar (DIN: 10756299), as Additional Director in the capacity of Executive Director of the company. The Board of Directors have considered and approved the schedule of 13th AGM and other matters. (As Per BSE Announcement dated on 30.08.2024)
12-May-2024 20-May-2024 Accounts Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve Audited Financial Results along with the Audit Report for the Half Year and Year ended on March 31 2024. Financial Results for the Half year and year ended March 31, 2024 Financial Results March 31, 2024 (As per BSE Announcement Dated on 20/05/2024)
12-Apr-2024 12-Apr-2024 Others The Board of Directors of the Company in it's meeting held today accorded its consent to sale/dispose or otherwise deal with the all assets of the Company together with all specified tangible or intangible assets, in relation to the Undertaking on a slump sale basis on an 'as is where is' basis or substantial parts or in any other manner to the potential investors/ buyers/ third-parties as the Board may deem fit in the overall interest of all the stakeholders. The above decision was taken to make the Company asset light and carry out the hospital business on lease/ profit sharing basis. Pursuant to Section 180(1)(a) of the Companies Act, 2013 and Regulation 37A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the approval of the members of the Company for the aforementioned matter shall be sought in ensuing General meeting of the Company which will be held on Tuesday, 14th May, 2024.
21-Mar-2024 21-Mar-2024 Change in Auditors Appointment of Statutory Auditor
04-Nov-2023 11-Nov-2023 Quarterly Results Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve the Unaudited Financial Results along with the Limited Review Report for the Half year ended on September 30 2023 and other matters. Board Meeting Outcome for approval of Unaudited Financial Results for the Half Year ended on September 30, 2023 (As Per BSE Announcement dated on 11.11.2023)
01-Nov-2023 01-Nov-2023 Change in Other Executives Appointment of Company Secretary and Compliance Officer of the company Appointment of Ms. Tanvi Solanki as Company Secretary and Compliance Officer
21-Aug-2023 21-Aug-2023 Change in Auditors The Board of Directors of the Company have considered and approved the schedule of 11th Annual General Meeting of the company and other matters.
19-May-2023 30-May-2023 Accounts Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve the Audited Financial Results along with the Audit Report for the Half year and Year ended on March 31 2023 and other items as may be decided by the Board of Directors of the Company. Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results along with the Audit Report for the Half year and Year ended on March 31, 2023 and any other items as may be decided by the Board of Directors of the company. (As per BSE Announcement Dated on 26/05/2023) Outcome of Meeting of Board of Directors held today i.e. Tuesday, 30th day of May, 2023, in terms of Regulation 30 of SEBI (LODR) Regulations, 2015, for consideration and approval of Annual Financial Results for the Half Year and Year ended on March 31, 2023, along with the Audit Report. (As Per BSE Announcement dated on 30.05.2023)
07-Nov-2022 12-Nov-2022 Half Yearly Results Half Yearly Results Unaudited Financial Result for the Half Year Ended on September 30, 2022 (As Per BSE Announcement Dated 12.11.2022)
29-Aug-2022 29-Aug-2022 AGM The Board of Directors of the Company had considered and approved the following agendas: 1. Re-appointment of M/s KARMA & Co. LLP, Chartered Accountants as Statutory Auditor. 2. Adoption of Board of Directors Report for FY 2021-2022. 3. 10th Annual General Meeting of the company will be held on Monday, September 26, 2022, at 01:30 P. M. IST through Video Conferencing and other Audio Visual. 4. Re-appointment of Ms. Sucheta Jani who retire by Rotation and eligible her-self for re-appointment in the 10th Annual General Meeting. Re-appointment of Statutory Auditor of the company
23-May-2022 30-May-2022 Accounts Audited Results Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve Audited Financial Results For The Half Year And Year Ended On March 31, 2022 (As Per BSE Announcement dated on 23.05.2022) Audited Financial Result For The Half Year And Year Ended On March 31, 2022. Appointment of Internal Auditor and Secretarial Auditor for the FY 2022-2023 (As Per BSE Announcement Dated on 30/05/2022)
1 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +